Debates em Psiquiatria (Feb 2023)

Use of Hericium erinaceus as a potential therapeutic of mental disorders: a systematic review

  • Pietra McDonnel Matheus Cortonesi,
  • Laura Fogaça de Almeida,
  • Rafael Monteiro Tancredi Pinheiro,
  • Cintia de Azevedo-Marques Périco,
  • João Maurício Castaldelli-Maia

DOI
https://doi.org/10.25118/2763-9037.2023.v13.443
Journal volume & issue
Vol. 13

Abstract

Read online

Introduction: Hericium erinaceus (HE), often known as Lion's Mane, is an edible fungus that has been extensively explored for its many functions. The use of this mushroom in traditional Chinese medicine dates back many years, and it is now being tested in the treatment of cognitive decline and Alzheimer's disease, and mental diseases like depression, anxiety, schizophrenia. Methods: We followed 2020 PRISMA statement for systematic reviews. The three selected databases were Worldcat®, Cochrane Library®, and PubMed®. On March 7, 2022, a search for articles was conducted. The search sources' descriptions were Hericium erinaceus AND (mental disorders OR cognitive impairment OR depression OR anxiety). "English" was the sole filter applied to the data sources. Results: Three Japanese randomized double-blind controlled trials were included in the review. Although the data demonstrated that HE can be useful in treating symptoms of cognitive impairment and moderate cognitive impairment, it was not effective in treating depression/anxiety symptoms. Conclusions: More studies are needed in countries besides Japan, lasting at least 12 weeks, since shorter periods do not demonstrate significant improvement of symptoms. Incorporating HE into a patient's daily diet may produce favorable benefits by alleviating cognitive decline.

Keywords